[HTML][HTML] Angiogenic endothelial cell signaling in cardiac hypertrophy and heart failure
R Gogiraju, ML Bochenek, K Schäfer - Frontiers in cardiovascular …, 2019 - frontiersin.org
Endothelial cells are, by number, one of the most abundant cell types in the heart and active
players in cardiac physiology and pathology. Coronary angiogenesis plays a vital role in …
players in cardiac physiology and pathology. Coronary angiogenesis plays a vital role in …
Copper promotion of myocardial regeneration
Y Xiao, T Wang, X Song, D Yang… - Experimental …, 2020 - journals.sagepub.com
Myocardial regeneration is the key to the functional recovery of ischemic heart.
Angiogenesis plays a pivotal role in myocardial regeneration by resetting a rejuvenation …
Angiogenesis plays a pivotal role in myocardial regeneration by resetting a rejuvenation …
Apigenin suppresses TGF-β1-induced cardiac fibroblast differentiation and collagen synthesis through the downregulation of HIF-1α expression by miR-122-5p
W Feng, Z Ying, F Ke, X Mei-Lin - Phytomedicine, 2021 - Elsevier
Background Apigenin can reduce cardiomyocyte hypertrophy by downregulating hypoxia
inducible factor-1 alpha (HIF-1α) expression. However, its effects on cardiac fibroblasts …
inducible factor-1 alpha (HIF-1α) expression. However, its effects on cardiac fibroblasts …
Statins reverse postpartum cardiovascular dysfunction in a rat model of preeclampsia
K Kräker, JM O'Driscoll, T Schütte, F Herse, O Patey… - …, 2020 - Am Heart Assoc
Preeclampsia is associated with increased cardiovascular long-term risk; however, the
underlying functional and structural mechanisms are unknown. We investigated maternal …
underlying functional and structural mechanisms are unknown. We investigated maternal …
Bovine milk exosomes alleviate cardiac fibrosis via enhancing angiogenesis in vivo and in vitro
C Zhang, X Lu, J Hu, P Li, J Yan, X Ling… - Journal of Cardiovascular …, 2022 - Springer
Cardiac fibrosis is a difficult clinical puzzle without effective therapy. Exosomes play an
important role in alleviating cardiac fibrosis via angiogenesis. This research aimed to assess …
important role in alleviating cardiac fibrosis via angiogenesis. This research aimed to assess …
Leech extract: a candidate cardioprotective against hypertension-induced cardiac hypertrophy and fibrosis
Ethnopharmacological relevance The prevalence of cardiovascular diseases (CVDs) has
been increasing worldwide. Despite significant improvements in therapeutics and on-going …
been increasing worldwide. Despite significant improvements in therapeutics and on-going …
[HTML][HTML] A current view of G protein-coupled receptor-mediated signaling in pulmonary hypertension: finding opportunities for therapeutic intervention
D Strassheim, V Karoor, K Stenmark, A Verin… - Vessel Plus, 2018 - ncbi.nlm.nih.gov
Pathological vascular remodeling is observed in various cardiovascular diseases including
pulmonary hypertension (PH), a disease of unknown etiology that has been characterized …
pulmonary hypertension (PH), a disease of unknown etiology that has been characterized …
Copper promotes cardiac functional recovery via suppressing the transformation of fibroblasts to myofibroblasts in ischemia-infarcted monkey hearts
Y Xiao, Q Feng, L Huang, X Meng, P Han… - The Journal of …, 2023 - Elsevier
Myocardial ischemia leads to cardiac fibrosis along with copper (Cu) loss. Cu repletion
diminishes myocardial fibrosis and improves cardiac function. The transformation of …
diminishes myocardial fibrosis and improves cardiac function. The transformation of …
The effects on angiogenesis of relevant inorganic chemotherapeutics
T Marzo, D La Mendola - Current Topics in Medicinal …, 2021 - ingentaconnect.com
Angiogenesis is a key process allowing the formation of blood vessels. It is crucial for all the
tissues and organs, ensuring their function and growth. Angiogenesis is finely controlled by …
tissues and organs, ensuring their function and growth. Angiogenesis is finely controlled by …
Riboflavin ameliorates pathological cardiac hypertrophy and fibrosis through the activation of short-chain acyl-CoA dehydrogenase
H Peng, M Xie, X Zhong, Y Su, X Qin, Q Xu… - European Journal of …, 2023 - Elsevier
Short-chain acyl-CoA dehydrogenase (SCAD), the rate-limiting enzyme for fatty acid β-
oxidation, has a negative regulatory effect on pathological cardiac hypertrophy and fibrosis …
oxidation, has a negative regulatory effect on pathological cardiac hypertrophy and fibrosis …